Abiopharma

SELECTIVE INSURANCE GROUP INC (SIGIP) Reports the reporting period Financial Results SELECTIVE INSURANCE GROUP INC (SIGIP) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 6
• Net Income: 0.14
• EPS: Not disclosed
• Cash and equivalents: $0.43
  • anticipated inflationary trends for our loss and loss expenses;•Geopolitical developments, including ongoing wars and conflicts such as the recent military conflict in the Middle East, which have contributed to volatility in global energy markets, international shipping activity, and financial markets, and may exacerbate inflationary pressures, supply chain disruption, and insurance loss costs;•Uncertainties related to insurance premium rate increases and business retention;•Changes in insurance regulations that impact our ability to write and/or cease writing insurance policies in one or more states;•The effects of data privacy or cyber security laws and regulations on our operations;•Major defect or failure in our internal controls or information technology and application systems that result in marketplace brand damage, increased senior executive focus on crisis and reputational management issues, and/or increased expenses, particularly if we experience a significant privacy breach;•Potential tax or federal financial regulatory reform provisions that could pose certain risks to our operations;•Our ability to maintain favorable financial ratings, which may include sustainability considerations, from rating agencies, including AM Best, Standard & Poor’s, Moody’s, and Fitch;•Our entry into new markets and businesses; and•Other risks and uncertainties we identify in filings with the United States Securities and Exchange Commission, including our Annual Report on Form 10-K and other periodic reports.Investor Contact:Brad B. Wilson973-948-1283